v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues $ 4,177 $ 4,450 $ 14,133 $ 10,857
Cost of Revenues 1,255 1,186 4,037 2,966
Gross Profit 2,922 3,264 10,096 7,891
Operating Expenses        
Research and development 4,644 3,254 13,642 9,185
Sales and marketing 2,157 2,407 6,757 6,119
General and administrative 5,146 8,571 18,148 26,570
Acquisition-related costs 2 93 270 1,098
Impairment of goodwill 0 0 7,570 0
Amortization of intangibles 1,366 1,395 4,056 3,088
Total Operating Expenses 13,315 15,720 50,443 46,060
Loss from Operations (10,393) (12,456) (40,347) (38,169)
Other Income (Expense)        
Interest income (expense), net (240) (15) (62) 1,191
Loss on exchange of debt for equity 0 0 0 (30)
Recovery of valuation allowance on related party loan - held for sale 0 0 0 7,345
Other (expense)/income, net (1,506) (47) (2,277) 464
Gain on related party loan - held for sale 0 0 0 49,817
Unrealized gain/(loss) on equity securities (5,854) (22,285) (7,110) (51,250)
Total Other Income (Expense) (7,600) (22,347) (9,449) 7,537
Net Loss, before tax (17,993) (34,803) (49,796) (30,632)
Income tax benefit/(provision) 0 854 (84) (1,350)
Net Loss (17,993) (33,949) (49,880) (31,982)
Net Loss Attributable to Non-controlling Interest (402) (309) (1,206) (544)
Net Loss Attributable to Stockholders of Inpixon (17,591) (33,640) (48,674) (31,438)
Net Loss Attributable to Common Stockholders (22,631) (36,602) (64,850) (34,400)
Net Loss Attributable to Common Stockholders $ (22,631) $ (36,602) $ (64,850) $ (34,400)
Net Income (Loss) Per Share        
Net Loss Per Share - Basic (in usd per share) $ (10.21) $ (22.31) $ (31.08) $ (23.95)
Net Loss Per Share - Diluted (in usd per share) $ (10.21) $ (22.31) $ (31.08) $ (23.95)
Weighted Average Shares Outstanding        
Basic (in shares) 2,216,544 1,640,971 2,086,633 1,436,093
Diluted (in shares) 2,216,544 1,640,971 2,086,633 1,436,093
Series 7 Convertible Preferred Stock        
Other Income (Expense)        
Accretion of preferred stock $ 0 $ (2,962) $ (4,555) $ (2,962)
Series 8 Convertible Preferred Stock        
Other Income (Expense)        
Accretion of preferred stock (6,305) 0 (13,089) 0
Deemed dividend for the modification related to Series 8 Preferred Stock 0 0 (2,627) 0
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock 0 0 1,469 0
Amortization premium- modification related to Series 8 Preferred Stock $ 1,265 $ 0 $ 2,626 $ 0

Source